| Literature DB >> 31154707 |
Trevor Simcox1, Derek Antoku1, Nickul Jain1, Frank Acosta1,2, Raymond Hah1,2.
Abstract
This comprehensive narrative literature review aims to extract studies related to frailty indices and their use in elective spine procedures, as limited studies regarding frailty exist in the spine literature. Most studies are retrospective analyses of prospectively collected databases. Evidence suggests a positive correlation between frailty level and mortality rate, postoperative complication rate, length of stay, and the possibility of discharge to a skilled nursing facility; these correlations have been illustrated across various spine procedures. The leading index is the modified frailty index, which measures 11 deficits. The development of more comprehensive frailty indices, such as the Adult Spinal Deformity Frailty Index, are promising and have high predictive value regarding postoperative complication rate in patients with spinal deformity. However, a frailty index that combines clinical, radiographic, and laboratory measures awaits development. Perhaps, the use of a frailty index in preoperative risk stratification for elective spine procedures could serve multiple purposes, including screening for high-risk patients, enhancement of operative decision making, approximation of complication rate for informed decision making, and refinement of perioperative care. Further prospective studies are warranted to determine clinically meaningful interventions in frail individuals.Entities:
Keywords: Adverse events; Elective surgical procedure; Frailty; Mortality; Spine
Year: 2019 PMID: 31154707 PMCID: PMC6773997 DOI: 10.31616/asj.2018.0239
Source DB: PubMed Journal: Asian Spine J ISSN: 1976-1902
Comparison of frailty indices found in spine literature
| mFI | ASD-FI | CCI |
|---|---|---|
| Cerebrovascular problems; respiratory problems; congestive heart failure; myocardial infarction; decreased peripheral pulses; arterial hypertension; cardiac problems; changes in everyday activity; clouding or delirium; history of stroke; history of diabetes mellitus | Documented by physician: >3 medical problems; body mass index (kg/m2) <18.5 or >30.0; cancer; cardiac disease; currently on disability; depression; diabetes; hypertension; liver disease; lung disease; osteoporosis; peripheral vascular disease; pervious blood clot (deep vein thrombosis/pulmonary embolism/stroke); smoking status | 1-Point clinical conditions: myocardial infarct; congestive heart failure; peripheral vascular disease; cerebrovascular disease; dementia; chronic pulmonary disease; connective tissue disease; ulcer disease; mild liver disease; diabetes |
| Patient–reported (questionnaire): bladder incontinence; bowel incontinence; deteriorating health this year; difficulty climbing 1 flight of stairs; difficulty driving a car; difficulty getting dressed; difficulty getting in/out of bed; difficulty sleeping >6 hours; difficulty walking 91.44 m; difficulty with light activity; feeling downhearted/depressed most of the time; feeling tired most of the time; feeling worn out most of the time; general health (fair/poor); inability to bathe without assistance; inability to cheer up often; inability to do normal work/schoolwork/housework; inability to lift heavy objects; inability to travel >1 hour; inability to walk without assistive device; leg weakness; loss of balance; not in excellent health; personal care dependency; restricted activity level; restricted social life | 2-Point clinical conditions: hemiplegia; moderate to severe renal disease; diabetes with end organ damage; any tumor; leukemia; lymphoma | |
| 3-Point clinical conditions: moderate to severe liver disease | ||
| 6-Point clinical conditions: metastatic solid tumor; acquired immune deficiency syndrome | ||
| mFI=Σdeficits/11 total deficits | ASD-FI=Σdeficits/40 total deficits | CCI=Σpoints |
| Significantly frail: mFI ≥0.21 to 0.36[ | Not frail: CD-FI <0.3; frail: CD-FI 0.3–0.5; severely frail: CD-FI >0.5 [ | No comorbidities: CCI ≤1; minor comorbidities: CCI 2–3; severely comorbidities: CD-FI ≥4 [ |
mFI, modified frailty index; ASD-FI, Adult Spinal Deformity Frailty Index; CCI, Charlson Comorbidity Index; CD-FI, Cervical Deformity Frailty Index.
Varies by study.
Summary table of literature pertaining to the frailty index and complication rates following elective spine surgery
| Reference | Procedure type | Study size/database | Frailty index | Follow-up period | Study outcomes | Findings | Conclusions |
|---|---|---|---|---|---|---|---|
| Ali et al. [ | All spine surgeries in ACS-NSQIP between 2006–2010 | 18,294/ACSNSQIP | mFI: significant frailty, mFI ≥0.27 | 30 Days | 30-Day rates of wound infection, any infection, Clavien-Dindo Class IV complications, and mortality | Found a dose-respond relationship between mFI and complication rate. As mFI increased from 0 to ≥0.27: mortality rate increased 0.1% to 2.3% ( | mFI score is independent predictor of postoperative morbidity and mortality in this population. Study failed to demonstrate predictive superiority of inferiority of mFI relative to ASA classification system, but mFI score ≥0.27 had greater odds of developing Clavien-Dindo class IV complications compared to ASA. |
| Shin et al. [ | ACDF | 6,148/ACS-NSQIP | mFI: significant frailty, mFI ≥0.27 | 30 Days | 30-Day rates of mortality, Clavien-Dindo grade IV complications, any complications, HAC including surgical site infection, UTI, and VTE. | As mFI increased from 0 to ≥0.27: morality rate increased 0.1% to 3.0% ( | mFI score ≥0.27, age >75 yr and ASA class >3 were all found to be independent predictors of Clavien class 4 complications. |
| mFI ≥0.27 independently predicts Clavien IV complication rate (OR, 4.67; 95% CI, 2.27–9.62). | Rates for all outcome variables assessed increased in a stepwise fashion with increasing mFI for both ACDF and PCF. | ||||||
| Shin et al. [ | PCF | 817/ACS-NSQIP | mFI: significant frailty, mFI ≥0.36 | 30 Days | 30-Day rates of mortality, Clavien-Dindo grade IV complications, any complications, HAC including surgical site infection, UTI, and VTE. | As mFI increased from 0 to ≥0.36: morality rate increased 0.0% to 10.0% ( | Age >75 yr and ASA class >3 were not found to be independent predictors of class 4 complications. |
| mFI ≥0.36 independently predicts Clavien IV complication rate (OR, 41.26; 95% CI, 6.62–257.15). | |||||||
| Medvedev et al. [ | PCF | 5,627/ACS-NSQIP | Frailty Based Risk Score—comprised of 21 clinical, functional, and laboratory deficits. | 30 Days | 30-Day rates of major and minor complications, readmission, and reoperation. Major complication defined as those that result in permanent sequelae or reoperation. Minor complications resolved without consequence. | Frailty score was a significant predictor of: ‘all complications’ (OR, 1.78; 95% CI, 1.61–1.96), readmission (OR, 1.40; 95% CI, 1.22–1.62), prolonged intubation (OR, 2.54; 95% CI, 2.00–3.22), and reintubation (OR, 2.34; 95% CI, 1.82–3.02). | Frailty score was found to be an independent predictor of reoperation, readmission, intubation related complications, unplanned re-intubation, and allcause complication rate. |
| Miller et al. [ | Cervical spine | 61/ISSG database | CD-FI—uses 40 vari- | ≥1 Year | Primary outcome: incidence of major complications, defined as complications that were potentially life-threatening, required reoperation, or created permanent injury. | On multivariate logistic regression, odds of major complication were significantly greater for SF patients (OR, 43; 95% CI, 2.7–684) compared with NF patient. Greater frailty associated with greater odds of major complication (OR, 7.6; 95% CI, 1.5–38.4). | Increasing frailty was associated with increasing risk of major complications. Postoperative medical complications were more highly correlated with frailty than were surgical complications. LOS and discharge disposition not related to degree of frailty in this study. |
| deformity surgery | for adult cervical spine deformity | ables found in ISSG cervical deformity database; NF, CD- FI <0.2; frail, CD-FI 0.2–0.4; SF, CD-FI >0.4 | Secondary outcomes: hospital LOS, discharge disposition, and medical/surgical complication rates. | Institutional discharge and prolonged LOS did not correlate significantly with CD-FI. | |||
| Leven et al. [ | ASD surgery | 1,001/ACS-NSQIP | mFI: significant frailty, mFI ≥0.27 | 30 Days | 30-Day mortality and complications including pneumonia, sepsis, DVT, PE, wound complications, deep infection, central nervous system complication, sepsis/septic shock, cardiac arrest, acute renal failure, UTI, reoperation. | As mFI increased from 0 to 0.27: mortality increased 0.3% to 10%, complication rate increased 35% to 60%, blood transfusion increased 32% to 55%, and PE/DVT increased 1.3% to 5% (all | Patients with higher mFI scores had higher rates of mortality, blood transfusions, PE/DVT, and any postoperative complications ( |
| Risk stratifying patients using mFI score of ≥0.18 was better predictor of reoperation than patient characteristics of age ≥60 yr and obesity class ≥III. | mFI of ≥0.27 shown to be optimal cutoff with respect to several complications, mortality, and reoperation risk. | ||||||
| Miller et al. [ | ASD surgery | 417/ISSG–ASD prospective patient database | ASD-FI: NF, CD-FI <0.3; frail, CD-FI 0.3–0.5; SF, CD-FI >0.5 | ≥2 Years | Primary outcome: incidence of major complications, defined as complications that were potentially life-threatening, required reoperation, or created permanent injury. | When compared to NF reference group: frail group had significantly greater odds of any complication ( | After controlling for complexity of procedure, frailty is independently associated with longer LOS and higher overall complication, major complication, and reoperation rates. Increasingly severe frailty is associated with increased postoperative incidence of PJK, pseudo-arthrosis, wound dehiscence, and deep wound infection. |
| Secondary outcomes: incidence of deep wound infection rate, wound dehiscence incidence, LOS, PJK, pseudo-arthrosis incidence, and reoperation rate. | |||||||
| Miller et al. [ | ASD surgery | 266/ESSG database | ASD-FI (truncated to 36 variables): NF, CD-FI <0.3; frail, CD-FI 0.3–0.5; SF, CD-FI >0.5 | ≥2 Years | Primary outcome: major perioperative complications, defined as complications that substantially changed expected path to recovery, were potentially life threatening, required reoperation, or caused permanent injury. | Compared to NF patients, frail and SF patients had higher odds of experiencing a major complication with OR 1.8 (95% CI, 1.0–33), and OR 2.6 (95% CI, 1.3–5.5), respectively. | Measurement of frailty using the ASD-FI in the ESSG database showed that frail and SF patients, compared to nonfrail patients, had significantly greater odds of developing a major complication, PJK, deep wound infection, and reoperation. Elevated frailty was associated with longer hospital stays. |
| Secondary outcomes: length of hospital stay, reoperation, PJK, deep wound infection, and surgical/medical complications. | On multivariable analysis SF compared to NF patients had higher odds of developing PJK (OR, 7.0; 95% CI, 1.4–34), wound infection (OR, 9.7; 95% CI, 2.3–41) and reoperation (OR, 3.9; 95% CI, 1.7–8.9). Compared to NF, frail and SF patients had significantly longer hospital LOS. | ||||||
| Reid et al. [ | ASD surgery with ≥4 level instrumented fusion | 332/ISSG–ASD database | ASD-FI: NF, CD-FI <0.3; frail, CD-FI 0.3–0.5; SF, CD-FI >0.5 | ≥2 Years | Postoperative HRQoL scores including ODI scores, SF-36 PCS scores, numeric back pain scores, and numeric leg pain scores; collected at 2 years postoperatively. Primary study outcome was if patients reached SCB for aforementioned scores. | Baseline HRQoL and pain scores were significantly worse in frail patient groups than the non-frail group ( | Despite higher preoperative risk stratification scores, increased complication rates, and worse baseline HRQoL scores: frail patients undergoing ASD surgery were more likely to reach SCB for most HRQoL measures following compared to NF Group. SF were least likely to reach SCB for most HRQoL measures. |
| Yagi et al. [ | Surgery for ASD, DS, and LSCS | 156 (ASD), 152 (DS), 173 (LSCS) | mFI: NF, mFI=0; pre-frail, mFI <0.21; frail, mFI >0.21 | ≥2 Years | Primary outcome: postoperative clinical outcomes and complication rate. | Postoperative ODI scores in ASD subjects deteriorated as mFI increased. In DS and LSCS subjects, clinical outcome scores improved regardless of CCI severity. In ASD surgery, major complication rate significantly increased with increasing mFI (36% in non-frail to 81% in frail group). In DS group, complication rate tended to increase with mFI and CCI, but increase was not significant. | Postsurgical clinical outcomes improved regardless of frailty score for DS and LSCS groups but declined significantly in ASD subjects with elevated frailty scores. |
| CCI: no comorbidities, CCI £1; minor comorbidities, CCI 2–3; severely comorbidities, CD-FI ≥4 | Secondary outcomes: sagittal alignments and incidence of PJK and failure. | Complication rate in ASD surgery worsened with increases in m랴 and CCI. | |||||
| Ondeck et al. [ | PLF | 16,495/ACS-NSQIP | ASA; mFI; mCCI—truncated version of the CCI | 30 Days | 30-Day rates of any AE, severe AEs (coma, cardiac arrest, death, DVT, myocardial infarction), minor AEs (acute kidney injury, anemia requiring transfusion, pneumonia, surgical site infection, UTI, dehiscence), infectious AEs, extended hospital LOS, and discharge to higher level of care. | Both ASA and mFI outperformed the mCCI in discriminative ability across all adverse outcomes. ASA and mFI had statistically similar predictive value in 5 of 6 outcomes, but regarding LOS ASA outperformed mFI. | For PLF, the ASA and age have better discriminative abilities for perioperative adverse outcomes than the mFI and the mCCI. |
| Phan et al. [ | Anterior lumbar interbody fusion | 3,920/ACS-NSQIP | mFI | 30 Days | Death and any postoperative complication within 30 days. Complications categorized into larger cohorts such as: death, pulmonary complications, renal complications, etc. Other outcomes measured include LOS >5 days and return to operating room. | As mFI increased from 0 to 0.27, there was significant stepwise increase in overall complication rate from 10.8% to 32.7%. Risk of any complication increases by odds ratio of 2.4 between mFI of 0 vs. 0.27. | High mFI scores were independently associated with all-cause complication rate and pulmonary complication rate. |
| High frailty scores significant associated with greater risk of pulmonary complications but no significant association between high mFI score and UTI, VTE, LOS>5 days, return to operating room, nor mortality could be found. | |||||||
| Flexman et al. [ | DSD | 52,671/ACS-NSQIP | mFI: significantly frail: mFI ≥0.27 | 30 Days | 30-Day rates of death and major complications within 30 days (Clavien–Dindo grade ≥2), LOS, and discharge to facility. | The mFI was in independent predictor of 30-day rate of major complications ( | Frailty is an important predictor of clinically relevant outcomes in patients undergoing surgery for DSD. Also, the need for reoperation due to surgical site infection was strongly predicted by presence of frailty. |
| Charest-Morin et al. [ | Primary elective thoracolumbar surgery for non-complex DSD | 102/Spine Adverse Events Severity System ver. 2 | mFI: frail, mFI ≥0.21 | Not provided | Occurrence of any perioperative AE including, but not limited to, dural tear, instrumentation failure, positioning-related complications; postoperative anemia, cardiac complications, wound infection, delirium, electrolyte abnormalities, pneumonia, neuropathic pain, UTI, and urinary retention. All AEs graded on scale of 1–6, with major events defined as grade 3 or higher. Secondary outcomes include hospital LOS, discharge to facility, and inhospital mortality. | After controlling for invasiveness of procedure (using Spine Surgical Invasiveness Index, no relationship between NTPA and AEs (adjusted OR, 1.06; 95% CI, 0.91–1.23) nor between mFI and AEs (OR, 0.85 per 0.1 increase in mFI; 95% CI, 0.58–1.24) could be found. | Both mFI and NTPA were not predictive of AEs, LOS, or discharge to higher level of care. mFI, but not NTPA, predictive of death. |
| Sarcopenia measured by NTPA—obtained via computed tomography during preoperative assessment | mFI, but not NTPA, was associated with increased risk of death (OR, 3.12 per 0.1 increase in mFI score; 95% CI, 1.21–8.03). Neither mFI nor NTPA predicted LOS or discharge to facility. | Based on relatively low sample size, lack of surgical complexity, and low prevalence of frailty in study population, study is likely underpowered to detect relationship with respect to frailty and rate of AEs. |
mFI, modified frailty index; ASA, American Society of Anesthesiologists; ACDF, anterior cervical discectomy and fusion; HAC, hospital acquired conditions; UTI, urinary tract infection; VTE, venous thromboembolism; OR, odds ratio; CI, confidence interval; PCF, posterior cervical fusion; ISSG, International Spine Study Group; CD-FI, Cervical Deformity Frailty Index; NF, not frail; SF, severely frail; LOS, length of stay; ASD, adult spinal deformity; DVT, deep vein thrombosis; PE, pulmonary embolism; ASD-FI, Adult Spinal Deformity Frailty Index; PJK, proximal junctional kyphosis; ESSG, European Spine Study Group; HRQoL, health-related quality of life; ODI, Oswestry Disability Index; SF-36, 36-item Short-Form Health Survey; PCS, Physical Component Summary; SCB, substantial clinical benefit; DS, degenerative spondylolisthesis; LSCS, lumbar spinal canal stenosis; CCI, Charlson Comorbidity Index; AE, adverse event; PLF, posterior lumbar fusion; mCCI, modified Charlson Comorbidity Index; DSD, degenerative spine disease; NTPA, normalized total psoas area.
Fig. 1.The implementation of a FSI at a single medical center resulted in significant improvement in postoperative survival among frail patients. The Kaplan–Meier survival curves of cohorts before (A) and after (B) the FSI implementation. Individuals are stratified into cohorts based on the RAI, a 14-item frailty index. Stratification demonstrates that survival benefit was highest in individuals with the highest levels of frailty. The sample included all 9,153 patients (5,275 before FSI implementation and 3,878 after FSI implementation). Mantel-Cox log rank tests for differences in the survival distribution are as follows (p<0.001 for overall difference before and after FSI implementation). Before FSI implementation, the lowest 2 strata of frailty were different from each other and from all the other strata (all p<0.001). There was no difference between the 16 to 20 and 21 to 25 RAI strata (p=0.31), although the 16 to 20 RAI stratum was different from the highest 3 strata of frailty (all p<0.05). The 21 to 25 RAI stratum was not different from the 26 to 30 (p=0.16) or the 31 to 35 (p=0.24) RAI stratum, but it was different from the 36 to 62 RAI stratum (p=0.004). Although the lines of the highest 3 strata diverge, the differences did not reach statistical significance (all p>0.05); however, this is likely attributable to the low numbers in these RAI strata. After FSI implementation, the lowest frailty stratum was different from all others (p<0.001), but there was no difference between the next RAI strata (e.g., 11–15, 16–20, and 21–25; all p>0.20), although these 3 were different from the top 3 strata (all p<0.03). There was no difference between the top 3 strata (e.g., 26–30, 31–35, and 36–62; all p>0.50), but they were all different from each of the lowest 3 strata (all p<0.05). Hash marks indicate censored data. FSI, Frailty Screening Initiative; RAI, Risk Analysis Index. Reprinted from Hall et al. JAMA Surg 2017;152:233-40, with permission of American Medical Association [47].